Chemoinformaics analysis of 19-Carboxydigitoxigenin
| Molecular Weight | 145.158 | nRot | 2 |
| Heavy Atom Molecular Weight | 134.07 | nRig | 11 |
| Exact Molecular Weight | 145.074 | nRing | 1 |
| Solubility: LogS | -3.936 | nHRing | 1 |
| Solubility: LogP | 4.009 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 11 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 20.8607 |
| nHD | 3 | BPOL | 12.4733 |
| QED | 0.536 |
| Synth | 4.298 |
| Natural Product Likeliness | 2.496 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.007 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.41 |
| MDCK | 0.0000199 |
| BBB | 0.17 |
| PPB | 0.888225 |
| VDSS | 1.763 |
| FU | 0.162842 |
| CYP1A2-inh | 0.095 |
| CYP1A2-sub | 0.58 |
| CYP2c19-inh | 0.187 |
| CYP2c19-sub | 0.942 |
| CYP2c9-inh | 0.143 |
| CYP2c9-sub | 0.693 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.811 |
| CYP3a4-inh | 0.15 |
| CYP3a4-sub | 0.405 |
| CL | 12.472 |
| T12 | 0.157 |
| hERG | 0.012 |
| Ames | 0.009 |
| ROA | 0.024 |
| SkinSen | 0.33 |
| Carcinogencity | 0.609 |
| EI | 0.719 |
| Respiratory | 0.79 |
| NR-Aromatase | 0.03 |
| Antiviral | No |
| Prediction | 0.951995 |